Literature DB >> 605353

Crohn's disease. A long-term study of the clinical course in 186 patients.

L Bergman, U Krause.   

Abstract

A series of 186 patients with Crohn's disease treated during the period 1956--1968 was followed up. During the follow-up period about 95% of the patients had undergone resection or by-pass surgery. The patients operated on between 1956--1968 were followed up with reference to recurrence rate. The mean observation time was 10.5 years. The recurrence rate after resection was 51%. "Radical" resection gave 29% recurrences. "Non-radical" resection gave 84% recurrences. Patients who had undergone a primary "radical" resection needed fewer re-operations, had fewer recurrences and a better "quality of life" than patients with a "non-radical" first operation. The total mortality in operations or due to complications of Crohn's disease in the series was 5.4%. The mortality in connection with operations was 3.4%. The general health of the patients examined in 1975 (165 patients) was estimated; 87% were in very good general health, 9.1% had moderate subjective symptoms, and 3.6% had pronounced subjective symptoms.

Entities:  

Mesh:

Year:  1977        PMID: 605353     DOI: 10.3109/00365527709181353

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  14 in total

1.  European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Authors:  R Caprilli; M A Gassull; J C Escher; G Moser; P Munkholm; A Forbes; D W Hommes; H Lochs; E Angelucci; A Cocco; B Vucelic; H Hildebrand; S Kolacek; L Riis; M Lukas; R de Franchis; M Hamilton; G Jantschek; P Michetti; C O'Morain; M M Anwar; J L Freitas; I A Mouzas; F Baert; R Mitchell; C J Hawkey
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

2.  Effect of resection margins on the recurrence of Crohn's disease in the small bowel. A randomized controlled trial.

Authors:  V W Fazio; F Marchetti; M Church; J R Goldblum; C Lavery; T L Hull; J W Milsom; S A Strong; J R Oakley; M Secic
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

3.  Clinical relapse of Crohn's disease under standardized conservative treatment and after excisional surgery.

Authors:  E Dirks; H Goebell; K Schaarschmidt; S Förster; E Quebe-Fehling; F W Eigler
Journal:  Dig Dis Sci       Date:  1989-12       Impact factor: 3.199

Review 4.  Surgical treatment of Crohn's disease of the small bowel or ileocecum.

Authors:  L Hultén
Journal:  World J Surg       Date:  1988-04       Impact factor: 3.352

5.  The influence of microscopic disease at the margin of resection on recurrence rates in Crohn's disease.

Authors:  J C Cooper; N S Williams
Journal:  Ann R Coll Surg Engl       Date:  1986-01       Impact factor: 1.891

6.  Does microscopic involvement of the surgical margins after ileocecectomy in Crohn's patients predict early recurrence?

Authors:  Meir Zemel; Elian Solo; Hagit Tulchinsky
Journal:  Int J Colorectal Dis       Date:  2021-04-29       Impact factor: 2.571

7.  Postoperative recurrence in Crohn's disease. The effect of the initial length of bowel resection and operative procedure.

Authors:  L Ellis; P Calhoun; D L Kaiser; L E Rudolf; J B Hanks
Journal:  Ann Surg       Date:  1984-03       Impact factor: 12.969

8.  The long-term outcome of restorative operation in Crohn's disease: influence of location, prognostic factors and surgical guidelines.

Authors:  Y M Trnka; D J Glotzer; E J Kasdon; H Goldman; M L Steer; L D Goldman
Journal:  Ann Surg       Date:  1982-09       Impact factor: 12.969

9.  Crohn's disease of the distal ileum.

Authors:  C S Higgens; R N Allan
Journal:  Gut       Date:  1980-11       Impact factor: 23.059

Review 10.  Postsurgical recurrence of ileal Crohn's disease: an update on risk factors and intervention points to a central role for impaired host-microflora homeostasis.

Authors:  Michael F Cunningham; Neil G Docherty; J Calvin Coffey; John P Burke; P Ronan O'Connell
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.